Randomized Double-blind Placebo-controlled Clinical Study to Evaluate the Effects and Safety of Iron Prophylaxis With Ferro IBSA on Iron Homeostasis in Healthy Pregnant Women.
The clinical study aims to evaluate the effect of iron supplementation in preventing the onset of Iron Deficiency Anemia during pregnancy. The trial is designed as a double-arm, double-blind clinical study comparing iron supplementation versus placebo in pregnant women. The primary objective is to assess the efficacy of iron supplementation in maintaining adequate levels of hemoglobin throughout gestation, while secondary outcomes include maternal hematological parameters and pregnancy outcomes.
• Healthy Caucasian women aged 18-45 years.
• Single, viable pregnancy.
• Plasma ferritin levels in the first trimester ≤ 70 ng/mL.
• Hb levels in the first trimester ≥ 110 g/L.
• Understanding and signing of the informed consent.